This article revisits the original cost-effectiveness that was done for the DEC report and brings in other factors such as reduction of falls.  The same analysis is also applied to the STIMuSTEP.  The analysis shows that the ODFS and STIMuSTEP are cost effective devices within the terms set out by the National Institute for health and Clinical Excellence (NICE)